Last reviewed · How we verify

NCT04971252

Type 2 Diabetes Mellitus and Chronic Kidney Disease

Completed Last updated 9 January 2024
What this trial tests

trial testing Hematologic tests for patients with diabetes mellitus and chronic kidney disease in Renal Disorder Associated With Type II Diabetes Mellitus in 150 participants. Completed in 7 July 2023.

Timeline
7 July 2021
Primary endpoint
23 March 2023
7 July 2023

Quick facts

Lead sponsorSohag University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment150
Start date7 July 2021
Primary completion23 March 2023
Estimated completion7 July 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Sohag University

Who can join

Adults 18 to 75, any sex, with Renal Disorder Associated With Type II Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To investigate the effect of co existance of diabetes mellitus and chronic kidney disease on basic coagulation profile in comparison with diabetic patients with normal kidney function and non diabetic patients with chronic kidney disease

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Sohag University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04971252.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing